COMMUNIQUÉS West-GlobeNewswire

NANOBIOTIX présente de nouveaux résultats cliniques et précliniques confirmant le potentiel de NBTXR3 en Immuno-Oncologie, lors du congrès annuel du SITC

13/11/2017 - 08:02

Nanobiotix présente de nouveaux résultats cliniques et précliniques confirmant le potentiel de NBTXR3 en Immuno-Oncologie, lors du congrès annuel du SITC NBTXR3 activé par la radiothérapie induit une réponse [...]

NANOBIOTIX presented new clinical and pre-clinical data confirming NBTXR3's significant potential role in Immuno-Oncology at SITC Annual Meeting

13/11/2017 - 08:02

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3's significant potential role in Immuno-Oncology at SITC Annual Meeting NBTXR3 activated by radiotherapy induces a significant adaptive immune [...]

Xbrane Biopharma releases interim report for the period July to September 2017

13/11/2017 - 08:01

Press release 2017-11-13 Xbrane Biopharma ABs interim report for the period July - September 2017 is now available on the Company's website, www.xbrane.com . July to September Revenue SEK -47 thousand (-) EBITDA SEK -8, [...]

Novartis highlights its differentiated late stage pipeline at the R&D update and investor event

13/11/2017 - 07:01

RTH258 demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity and meets primary endpoint of non-inferiority in patients with nAMD AMG 334 has a robust data package, even in [...]

argenx to Present at Upcoming Investor Conferences

13/11/2017 - 07:01

November 13, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]

Voyager Therapeutics to Host R&D Day on November 16, 2017

13/11/2017 - 00:00

CAMBRIDGE, Mass., Nov. 12, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]

Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential Use in Patient Selection

11/11/2017 - 23:45

– Clinical Data from Renal Cell Carcinoma Cohorts Presented in Oral Session at SITC 32 nd Annual Meeting – – Adenosine Pathway Gene Expression Associated with Response to Therapy and Resistance to Prior Anti PD-(L)-1 – [...]

Nextech Named Tampa Bay “Technology Company of the Year” for 2017 at the 14th Annual Tampa Bay Tech Awards

11/11/2017 - 23:28

TAMPA, Fla., Nov. 11, 2017 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, has been named the Technology Company of the Year for 2017 by [...]

Argos Therapeutics Provides Update on Immunology Data from the Phase 3 ADAPT Trial Presented at the SITC 2017 Annual Meeting

11/11/2017 - 14:30

DURHAM, N.C., Nov. 11, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the [...]

Punjab province in Pakistan signs agreement with Novartis Access against chronic diseases

11/11/2017 - 14:01

Poor patients in Punjab will have access to high-quality medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access Punjab government will make medicines available [...]

CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC Annual Meeting

11/11/2017 - 02:00

- CRISPR-based CAR-T cell therapy candidates targeting CD19+, BCMA and CD70 demonstrate high editing rates, and potent anti-tumor activity in preclinical models - - Expanding applicability of CRISPR-based CAR-T therapy [...]

TOMI Environmental Solutions, Inc. to Hold Third Quarter 2017 Financial Results Conference Call on November 16, 2017

11/11/2017 - 00:40

BEVERLY HILLS, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination and infection prevention company that specializes in disinfection/ [...]

Restoration Robotics, Inc. to Participate in Two International Medical Meetings Focused on the Asia-Pacific Market

11/11/2017 - 00:24

SAN JOSE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ: HAIR ) announced today that the Company will participate in two international medical meetings focused on the Asia-Pacific market [...]

Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness

10/11/2017 - 23:52

Brolucizumab, the first and only anti-VEGF to maintain a majority of patients on a 12-week treatment schedule immediately following loading phase in Phase III trials, met primary endpoint of non-inferiority vs [...]

Three-year Follow-up Phase 3 Data Provide Additional Information on Efficacy, Durability and Safety of Investigational LUXTURNA™ (voretigene neparvovec) in Patients with Biallelic RPE65-mediated Inherited Retinal Disease

10/11/2017 - 23:05

PHILADELPHIA, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced new three-year [...]

Skyline Medical to Hold Business Update Conference Call on November 15, 2017

10/11/2017 - 23:00

MINNEAPOLIS, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

10/11/2017 - 22:15

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ: CBMX ) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and [...]

ZIOPHARM to Present at the Stifel 2017 Healthcare Conference

10/11/2017 - 22:05

BOSTON, Nov. 10, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP ) today announced that David Mauney, M.D., CBO and interim COO, will present at the Stifel 2017 Healthcare Conference in New York on [...]

Voyager Therapeutics Announces Closing of Public Offering of Common Stock

10/11/2017 - 22:05

CAMBRIDGE, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]